Clinical Trial Highlights

• ALPHA: T-Wave Alternans Testing Hospital
• EVEREST: Modest Gains from Tolvaptan in Heart Failure
• FUSION II: No Advantage for Serial Nesiritide Infusions
• VALIDD: Lowering Blood Pressure Improves Diastolic Dysfunction
• Torcetrapib Fails to Meet Expectations
• Ranolazine Reduces Recurrent Ischemia in Patients with Non-ST Elevation ACS
• The COURAGE Trial: Optimal Medical Therapy Equivalent to PCI
• Succinobucol Treatment Leads to Mixed Signals
• Hawthorn Extract in CHF Patients: Results of a Controlled Study
• Reconstituted HDL Infusions Look Promising